⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

Developing targeted therapies for serious respiratory diseases

Developing targeted therapies for serious respiratory diseases

Unclaimed

AEO Score: 5/10

Monitoring for AI engine activity

In the Engagemii AEO index

pulmocide.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Developing targeted therapies for serious respiratory diseases just got measured.

5/10 means Developing targeted therapies for serious respiratory diseases is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About Developing targeted therapies for serious respiratory diseases

Pulmocide is a biotechnology company developing novel inhaled medicines for pulmonary aspergillosis and other hard-to-treat respiratory diseases.

Key Topics

Developing targeted therapies for serious respiratory diseases

Details

Industry: Healthcare

pulmocide.com

AI Visibility Breakdown

2

Structured Data

8

Content Structure

6

Entity Clarity

5

E-E-A-T Signals

7

Technical AEO

3

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for Developing targeted therapies for serious respiratory diseases: Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Developing targeted therapies for serious respiratory diseases.

Source & Attribution

Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/pulmocide

Cite this score: Engagemii (2026). "AEO Score for Developing targeted therapies for serious respiratory diseases." Retrieved from https://engagemii.com/aeo/brands/pulmocide

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform